6 Results for "

transaminase reaction

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "transaminase reaction" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-W097899
CAS No.: 1196-92-5
Vanillylamine is an immediate precursor for capsaicinoids. Vanillylamine is a derivative of Vanillin (HY-N0098) is synthesized through a transaminase reaction in the phenylpropanoid pathway of capsaicinoid synthesis. Vanillylamine significantly alleviates myelosuppression caused by abdominal and pelvic tumor chemotherapy .
loading...
    loading...
Cat. No.: HY-W097899R
CAS No.: 1196-92-5
Vanillylamine is an immediate precursor for capsaicinoids. Vanillylamine is a derivative of Vanillin (HY-N0098) is synthesized through a transaminase reaction in the phenylpropanoid pathway of capsaicinoid synthesis. Vanillylamine significantly alleviates myelosuppression caused by abdominal and pelvic tumor chemotherapy .
loading...
    loading...
Cat. No.: HY-P3170
CAS No.: 61461-61-8
Research Areas:  

Infection

β-alanine-pyruvate transaminase is an enzyme. Dihydrouracil and dihydrothymine, as nitrogen sources, increase the activity of β-alanine-pyruvate transaminase in cultured B. cepacia cells. The activity of β-alanine-pyruvate transaminase can be measured by tracking the release of L-α-alanine during the reaction .
loading...
    loading...
Cat. No.: HY-E71806
Research Areas:  

Others

4-Aminobutyrate-pyruvate transaminase (EC 2.6.1.96) is a transferase that can catalyze multiple reactions, including reaction 1: convert 4-aminobutanoate and pyruvate into succinate semialdehyde and L-alanine; reaction 2: convert 4-aminobutanoate and glyoxylate into succinate semialdehyde and glycine.
loading...
    loading...
Cat. No.: HY-E71111
Research Areas:  

Others

(S)-3,5-Dihydroxyphenylglycine transaminase (EC 2.6.1.103) catalyses the reaction in the reverse direction as part of the biosynthesis of the (S)-3,5-Dihydroxyphenylglycine constituent of the glycopeptide antibiotic chloroeremomycin.
loading...
    loading...
Cat. No.: HY-L064
1,827 compounds

Glutamine is an important metabolic fuel that helps rapidly proliferating cells meet the increased demand for ATP, biosynthetic precursors, and reducing agents. Glutamine Metabolism pathway involves the initial deamination of glutamine by glutaminase(GLS), yielding glutamate and ammonia. Glutamate is converted to the TCA cycle intermediate α-ketoglutarate (α-KG) by either glutamate dehydrogenase (GDH) or by the alanine or aspartate transaminases (TAs), to produce both ATP and anabolic carbons for the synthesis of amino acids, nucleotides and lipids. During periods of hypoxia or mitochondrial dysfunction, α-KG can be converted to citrate in a reductive carboxylation reaction catalyzed by IDH2. The newly formed citrate exits the mitochondria where it is used to synthesize fatty acids and amino acids and produce the reducing agent, NADPH.

Cancer cells display an altered metabolic circuitry that is directly regulated by oncogenic mutations and loss of tumor suppressors. Mounting evidence indicates that altered glutamine metabolism in cancer cells has critical roles in supporting macromolecule biosynthesis, regulating signaling pathways, and maintaining redox homeostasis, all of which contribute to cancer cell proliferation and survival. Thus, intervention in glutamine metabolic processes could provide novel approaches to improve cancer treatment.

MCE owns a unique collection of 1,827 compounds targeting the mainly proteins and enzymes involved in glutamine metabolism pathway. Glutamine Metabolism compound library is a useful tool for intervention in glutamine metabolic processes.